Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?
Pietro Majno, Emiliano Giostra, Gilles Mentha – 29 October 2007
Pietro Majno, Emiliano Giostra, Gilles Mentha – 29 October 2007
Benjamin L. Shneider, George V. Mazariegos – 29 October 2007
Seong Hoon Kim, Jun‐sik Yoo, Sung‐Sik Han, Sang Jae Park, Soon‐ae Lee, Woo Jin Lee, Joong‐Won Park, Chang‐Min Kim – 29 October 2007
Christine Carter‐Kent, Kadakkal Radhakrishnan, Ariel E. Feldstein – 29 October 2007
Charissa Y. Chang, Ashwani K. Singal, Sri V. Ganeshan, Thomas D. Schiano, Robert Lookstein, Sukru Emre – 29 October 2007 – Recurrent venous thrombosis following liver transplantation for Budd‐Chiari syndrome is common, particularly in the setting of an underlying myeloproliferative disorder. We describe a patient who developed refractory ascites due to portal vein thrombosis following liver transplantation for Budd‐Chiari syndrome in the setting of paroxysmal nocturnal hemoglobinuria.
Silvina Yantorno, Federico Villamil – 29 October 2007
Michael L. Volk, Jose C. Hernandez, Anna S. Lok, Jorge A. Marrero – 29 October 2007 – The benefit of liver transplantation (LT) is determined not only by the severity of illness, but also by the likelihood of posttransplantation survival. Current models are unable to accurately predict which patients will have the best posttransplant survival. We hypothesized that the Charlson Comorbidity Index (CCI), which includes nine comorbidities, could be used to predict survival after LT. We performed a retrospective study of 624 patients undergoing LT, with a median follow‐up time of 4.3 yr.
Andrea DiMartini – 29 October 2007
Thomas P. Beresford – 29 October 2007
Vincenzo Mazzaferro – 29 October 2007